Healthcare provider profile · identity verified

Rachel Benelli Markey

Family Practice · EAST BERLIN, PA · NPI 1578895017

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	414	100
Levothyroxine Sodium	Levothyroxine Sodium	270	48
Omeprazole	Omeprazole	232	41
Lisinopril	Lisinopril	209	54
Amlodipine Besylate	Amlodipine Besylate	201	49
Pantoprazole Sodium	Pantoprazole Sodium	196	40
Losartan Potassium	Losartan Potassium	190	47
Metoprolol Succinate	Metoprolol Succinate	189	46
Furosemide	Furosemide	186	36
Metformin Hcl	Metformin Hcl	135	32
Gabapentin	Gabapentin	129	28
Hydrochlorothiazide	Hydrochlorothiazide	127	35
Sertraline Hcl	Sertraline Hcl	121	29
Escitalopram Oxalate	Escitalopram Oxalate	116	23
Eliquis	Apixaban	100	23
Simvastatin	Simvastatin	98	26
Rosuvastatin Calcium	Rosuvastatin Calcium	92	28
Tamsulosin Hcl	Tamsulosin Hcl	82	23
Clopidogrel	Clopidogrel Bisulfate	78	14
Pravastatin Sodium	Pravastatin Sodium	74	22
Bupropion Xl	Bupropion Hcl	72	14
Fluticasone Propionate	Fluticasone Propionate	72	22
Glipizide	Glipizide	72	17
Prednisone	Prednisone	70	50
Fenofibrate	Fenofibrate Nanocrystallized	69	suppressed
Trazodone Hcl	Trazodone Hcl	68	13
Spironolactone	Spironolactone	61	12
Jardiance	Empagliflozin	58	13
Albuterol Sulfate Hfa	Albuterol Sulfate	57	29
Fluoxetine Hcl	Fluoxetine Hcl	55	11
Lorazepam	Lorazepam	55	18
Duloxetine Hcl	Duloxetine Hcl	51	13
Tradjenta	Linagliptin	51	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	49	suppressed
Alendronate Sodium	Alendronate Sodium	48	11
Breo Ellipta	Fluticasone/Vilanterol	48	suppressed
Chlorthalidone	Chlorthalidone	47	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	47	14
Metformin Hcl Er	Metformin Hcl	46	14
Ezetimibe	Ezetimibe	45	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	45	14
Ozempic	Semaglutide	42	suppressed
Pregabalin	Pregabalin	39	suppressed
Tramadol Hcl	Tramadol Hcl	39	12
Famotidine	Famotidine	37	suppressed
Mirtazapine	Mirtazapine	37	suppressed
Januvia	Sitagliptin Phosphate	36	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	36	24
Montelukast Sodium	Montelukast Sodium	34	suppressed
Potassium Chloride	Potassium Chloride	34	suppressed
Baclofen	Baclofen	33	suppressed
Buspirone Hcl	Buspirone Hcl	33	14
Valsartan	Valsartan	33	suppressed
Hydralazine Hcl	Hydralazine Hcl	32	suppressed
Atenolol	Atenolol	29	suppressed
Finasteride	Finasteride	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Carvedilol	Carvedilol	25	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	25	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Celecoxib	Celecoxib	24	suppressed
Naproxen	Naproxen	24	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Aripiprazole	Aripiprazole	20	suppressed
Clobetasol Propionate	Clobetasol Propionate	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Mounjaro	Tirzepatide	19	suppressed
Fluconazole	Fluconazole	18	14
Azithromycin	Azithromycin	17	suppressed
Cephalexin	Cephalexin	17	12
Meloxicam	Meloxicam	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	16	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Topiramate	Topiramate	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Bumetanide	Bumetanide	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Torsemide	Torsemide	15	suppressed
Allopurinol	Allopurinol	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	12
Clonazepam	Clonazepam	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Sotalol	Sotalol Hcl	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	13
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Topiramate Er	Topiramate	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Concerta	Methylphenidate Hcl	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Nyamyc	Nystatin	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed
Verapamil Sr	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error